Understanding how metabolic and inflammatory changes lead to heart failure
Official title: Trajectories to Heart Failure: Immunometabolic Mechanisms
Funded at Keystone Symposia · NIH-11068984 · Data updated 2026-11-12
This study is all about a conference where experts will talk about how inflammation and metabolism affect heart failure and other heart problems, with the goal of finding new ways to treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | January 1, 2025 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $13,000 |
| NIH project number | 1R13HL177931-01 |
| Project ID | NIH-11068984 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for heart failure or those with existing cardiovascular diseases, particularly those with metabolic or inflammatory conditions.
✕Less likely to help
Patients who do not have cardiovascular diseases or metabolic disorders may not benefit from this research.
What this research studies
This research focuses on a conference that will gather experts to discuss the role of metabolic and inflammatory changes in the development of heart failure and related cardiovascular diseases. The conference will explore how chronic low-grade inflammation, known as 'metainflammation', contributes to conditions like heart failure and atherosclerosis. Attendees will engage in discussions that bridge basic research and clinical insights, aiming to foster collaborations that could lead to new treatments and understanding of these diseases.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential treatments for heart failure and related cardiovascular conditions.
How similar studies have gone: Previous conferences and research in related fields have shown success in advancing understanding and treatment of cardiovascular diseases through collaborative discussions.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.